Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
about
Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loadingExpression of cancer/testis antigens in cutaneous T cell lymphomas.Cutaneous T-cell Lymphoma.Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patientsp16(INK4a) gene alterations are frequent in lesions of mycosis fungoides.A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites.Interleukin-7 is a growth factor for Sézary lymphoma cellsMorphologic and immunologic characterization of 50 peripheral T-cell lymphomas.Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma.Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigenImmunotactoid glomerulopathy associated with mycosis fungoidesThe diagnosis, staging, and treatment options for mycosis fungoides.Classification and treatment of rare and aggressive types of peripheral T-cell/natural killer-cell lymphomas of the skin.Photopheresis: a new therapeutic concept.Diagnosis of cutaneous T cell lymphoma by use of monoclonal antibodies reactive with tumor-associated antigens.Phototherapy and photopharmacology.Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoidesTh17 cells: a new therapeutic target in inflammatory dermatoses.Dermatology-epitomes of progress: new developments in the staging and therapy of mycosis fungoides.Dohi memorial lecture. Cutaneous T cell lymphoma.Applications of monoclonal antibodies to the in situ detection of human leucocytes.Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma.The behavior of epidermotropic lymphoma in twenty-five dogsMimotopes for tumor-specific T lymphocytes in human cancer determined with combinatorial peptide libraries.Aberrant responses of human lymphocytic neoplasms to cytokine regulation.Ultrastructural morphometric analysis of normal human lymphocytes stimulated in vitro with mitogens and antigens.Human T cell lymphotropic virus type I and cutaneous T cell leukemia/lymphoma.Improved generation of anti-tumor immunity by antigen dose limitation.Variably acid-fast pleomorphic bacteria as a possible cause of mycosis fungoides. A report of a necropsied case and two living patients.Expression of Epstein-Barr virus in cutaneous T-cell lymphoma including mycosis fungoides.Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.Tumour-specific cytotoxic T lymphocyte activity in Th2-type Sézary syndrome: its enhancement by interferon-gamma (IFN-gamma) and IL-12 and fluctuations in association with disease activity.CD30 positive anaplastic large-cell lymphoma mimicking Langerhans cell histiocytosis.Low expression of adhesion molecules in a case of cutaneous T-cell lymphoma.Cutaneous lymphomas in Tokyo: analysis of 62 cases in a dermatology clinic.Skin is the frequent site for involvement of peripheral T-cell and natural killer cell lymphomas in Korea.Current and Emerging Therapeutics for Cutaneous T-Cell Lymphoma: Histone Deacetylase InhibitorsCombination Phototherapy with a Histone Deacetylase Inhibitor and a Potent DNA-Binding Bibenzimidazole: Effects in Haematological Cell Lines
P2860
Q24815134-06CA52C9-230B-48B4-95E0-446BC69F1324Q31036179-4FE86AFA-0EDB-4F56-B218-C05BF1DF9946Q33889220-D8F75825-C906-4A1C-818E-3F956603F31DQ34230858-777FF787-DAFA-4159-9561-694920EC386FQ35810137-460575B7-D5CB-44BE-9579-8CC98972EA96Q35811240-F82D990F-BB8F-4C7B-A167-F2DE7822DE58Q35822493-858B64D8-10CE-4ED5-9EC2-DBB6868340DEQ35835004-38F0992C-3E18-4B33-B3AE-A56CC0049E65Q36258039-F2703775-198F-4376-92A8-3020A0005FF8Q36364822-98F33CF2-B4E2-458E-A3C4-6548674AE0B0Q36718185-48A33830-0347-4AB6-B602-84034AB5058DQ36771218-5D18CDCD-FC25-4D98-99E1-1414C61A7AABQ36771221-2C28EBDC-F081-4935-90D7-EB08525CDC36Q36987846-43B17662-640B-4770-86E0-C9100F9AFD5DQ36988433-890226CC-8307-4AEA-A259-1063BEE6AE68Q36989020-302693E7-21F6-4700-8FDF-66509EEE9A15Q37207596-03E0B6C6-1154-4BAD-9157-DB912CB83B51Q37216488-8D262AB5-9F4E-441C-BD95-4291A677E010Q39343261-7946CA16-06E9-41EC-B57D-700B76D246CEQ39466321-88BDC14B-6D4C-4565-B666-63C5A6D91CC6Q39479827-CF6CE818-1EC9-46EF-BB7E-2EEDBFF7993EQ39506116-47D13F53-933F-4B14-960B-D57D80CFD0AEQ40501041-C8A5C75C-A708-49A5-AC82-7D67F3C4DA49Q40828672-BCF0F456-7435-40A1-9A4B-AFCDB3811C30Q41710790-B00DAB9B-4CB0-4D36-9D4B-C08400F1E56FQ41870060-5E11DC7D-6141-4C1C-BDB4-D37043B7FBDAQ42942655-429B04B3-A6AC-4C6C-8A9B-3EFCA50550B9Q42951816-C259C2AD-8B16-40E0-9967-403219FFB6A7Q44548052-B83EC1F1-E4AE-43BF-A427-8D3539C06F24Q45737866-57677746-8BCB-4D09-A000-B1CFDDEEC7DEQ46302590-2310698F-B0B1-47BF-B863-E1F901DE84CBQ47901582-20E06E98-7B4A-4776-A631-DCCE177FD972Q51610455-992C17B2-3492-4048-85D6-65F12DBA80C0Q52051727-8355F3BF-88BC-4F88-90FF-47B22B5E674DQ55239841-8E949797-777C-4B91-85F9-92F5B12F7E89Q55239927-760B06A3-295B-43B7-84EA-8DB0CAD91276Q58698929-1C985D4B-10FB-4CAF-A69C-4BCFA311DA90Q58698941-1F05A24F-09FD-474B-B459-C77F2E4B811F
P2860
Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
@en
type
label
Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
@en
prefLabel
Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
@en
P1476
Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
@en
P2093
Edelson RL
P304
P356
10.1016/S0190-9622(80)80385-9
P407
P577
1980-02-01T00:00:00Z